The SARS-CoV ferret model in an infection–challenge study

Phase I human clinical studies involving therapeutics for emerging and biodefense pathogens with low incidence, such as the severe acute respiratory syndrome coronavirus (SARS-CoV), requires at a minimum preclinical evaluation of efficacy in two well-characterized and robust animal models. Thus, a f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chu, Yong-Kyu, Ali, Georgia D., Jia, Fuli, Li, Qianjun, Kelvin, David, Couch, Ronald C., Harrod, Kevin S., Hutt, Julie A., Cameron, Cheryl, Weiss, Susan R., Jonsson, Colleen B.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Elsevier Inc. 2008
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2831213/
https://ncbi.nlm.nih.gov/pubmed/18234270
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.virol.2007.12.032
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak